NRx Pharmaceuticals announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:30 p.m. Eastern Time on Monday, April 1. The company’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol “NRXP” and will begin trading on a split-adjusted basis when the market opens on Tuesday, April 2. The new CUSIP number for the company’s common stock following the reverse stock split will be 629444209.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRXP:
- Is NRXP a Buy, Before Earnings?
- NRX Pharmaceuticals Shareholders Approve Potential Reverse Split
- NRx Pharmaceuticals announces plan to distribute shares of HOPE Therapeutics
- NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
- NRx Pharmaceuticals initiates strategy to combat short sales
